The Cost of Saving Lives: A Step Forward in the Elimination of Rheumatic Heart Disease
A first of its kind study about the cost and benefit of investment in the prevention and management of Rheumatic Heart Disease (RHD) in the African Union was published today in the Lancet Global Health. The main finding is that mortality can be reduced by 30% over the next decade by investing USD 100 million annually in decentralizing and integrating cardiac care at rural primary care facilities and getting those with advanced disease on the right medicines and to cardiac surgery when needed. This means saving 70,000 lives.
Click Here to read more